: In recent years, the role of artificial intelligence (AI) and deep learning (DL) models is attracting increasing global interest in the field of ophthalmology. DL models are considered the current state-of-art among the AI technologies. In fact, DL systems have the capability to recognize, quantify and describe pathological clinical features. Their role is currently being investigated for the early diagnosis and management of several retinal diseases and glaucoma. The application of DL models to fundus photographs, visual fields and optical coherence tomography (OCT) imaging has provided promising results in the early detection of diabetic retinopathy (DR), wet age-related macular degeneration (w-AMD), retinopathy of prematurity (ROP) and glaucoma. In this review we analyze the current evidence of AI applied to these ocular diseases, as well as discuss the possible future developments and potential clinical implications, without neglecting the present limitations and challenges in order to adopt AI and DL models as powerful tools in the everyday routine clinical practice.

The upcoming role of Artificial Intelligence (AI) for retinal and glaucomatous diseases / Ferro Desideri L.; Rutigliani C.; Corazza P.; Nastasi A.; Roda M.; Nicolo M.; Traverso C.E.; Vagge A.. - In: JOURNAL OF OPTOMETRY. - ISSN 1888-4296. - STAMPA. - 15:Special Issue 1(2022), pp. S50-S57. [10.1016/j.optom.2022.08.001]

The upcoming role of Artificial Intelligence (AI) for retinal and glaucomatous diseases

Corazza P.;Roda M.;Nicolo M.;
2022

Abstract

: In recent years, the role of artificial intelligence (AI) and deep learning (DL) models is attracting increasing global interest in the field of ophthalmology. DL models are considered the current state-of-art among the AI technologies. In fact, DL systems have the capability to recognize, quantify and describe pathological clinical features. Their role is currently being investigated for the early diagnosis and management of several retinal diseases and glaucoma. The application of DL models to fundus photographs, visual fields and optical coherence tomography (OCT) imaging has provided promising results in the early detection of diabetic retinopathy (DR), wet age-related macular degeneration (w-AMD), retinopathy of prematurity (ROP) and glaucoma. In this review we analyze the current evidence of AI applied to these ocular diseases, as well as discuss the possible future developments and potential clinical implications, without neglecting the present limitations and challenges in order to adopt AI and DL models as powerful tools in the everyday routine clinical practice.
2022
The upcoming role of Artificial Intelligence (AI) for retinal and glaucomatous diseases / Ferro Desideri L.; Rutigliani C.; Corazza P.; Nastasi A.; Roda M.; Nicolo M.; Traverso C.E.; Vagge A.. - In: JOURNAL OF OPTOMETRY. - ISSN 1888-4296. - STAMPA. - 15:Special Issue 1(2022), pp. S50-S57. [10.1016/j.optom.2022.08.001]
Ferro Desideri L.; Rutigliani C.; Corazza P.; Nastasi A.; Roda M.; Nicolo M.; Traverso C.E.; Vagge A.
File in questo prodotto:
File Dimensione Formato  
The upcoming role of Artificial Intelligence (AI) for.pdf

accesso aperto

Tipo: Versione (PDF) editoriale
Licenza: Licenza per Accesso Aperto. Creative Commons Attribuzione - Non commerciale - Non opere derivate (CCBYNCND)
Dimensione 478.35 kB
Formato Adobe PDF
478.35 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11585/918401
Citazioni
  • ???jsp.display-item.citation.pmc??? 5
  • Scopus 10
  • ???jsp.display-item.citation.isi??? ND
social impact